New modes of surfactant delivery

Area of Science:

• Neonatal medicine
• Pediatric respiratory care
• Critical care for newborns

Background:

• Respiratory distress syndrome (RDS) is a major cause of morbidity and mortality in premature infants.
• Exogenous surfactant therapy has significantly improved outcomes for infants with RDS.
• The current standard, Intubate-SURfactant-Extubate (INSURE), involves invasive intubation and carries risks.

Purpose of the Study:

• To review and compare alternative, less invasive surfactant delivery methods for premature infants.
• To assess the clinical benefits and invasiveness of novel surfactant administration techniques.
• To provide an overview of options beyond the traditional INSURE method.

Main Methods:

• Review of current literature on surfactant administration techniques.
• Comparison of Less Invasive Surfactant Administration (LISA), Minimally Invasive Surfactant Therapy (MIST), aerosolization, laryngeal mask airway (LMA), and nasopharyngeal deposition.
• Analysis of reported clinical benefits and invasiveness levels for each method.

Main Results:

• Alternative methods like LISA and MIST aim to reduce the risks associated with endotracheal intubation.
• Aerosolization, LMA, and nasopharyngeal deposition represent a spectrum of less invasive approaches.
• Each method presents a unique balance of efficacy, safety, and technical challenges.

Conclusions:

• Less invasive surfactant administration strategies offer promising alternatives to INSURE for managing neonatal respiratory distress syndrome.
• Further research and standardization are needed to optimize these methods for widespread clinical adoption.
• Reducing invasiveness in surfactant delivery can enhance patient safety and potentially improve long-term outcomes for premature infants.